Becker, J., Mahmoudpour, S. H., Schadendorf, D., Leiter, U. M., Meier, F. E., Herbst, R. A., Grabbe, S., Gebhardt, C., Ziller, F., Pföhler, C., Mohr, P., Zimmer, L., Boutmy, E., Oksen, D., Kearney, M., Ruth, K., Hoff, S., Shlaen, M., Ugurel, S. (2025). Real-world safety and effectiveness of avelumab in immune-compromised (IC) and non-IC patients with Merkel cell carcinoma (MCC): Results from a prospective German registry (MCC-TRIM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.9543